This Article Full Text (PDF) All Versions of this Article: 1352458507076982v1 13/8/1068    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (14) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Roccatagliata, L. Search for Related Content PubMed PubMed Citation Articles by Roccatagliata, L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CYCLOPHOSPHAMIDE Medline Plus Health Information Multiple Sclerosis Social Bookmarking                         What's this?

The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study

Department of Neuroscience, Ophtalmology and Genetics, University of Genoa, Genoa

MA Rocca

Neuroimaging Research Unit, Department of Neurology, Scientific Institute and University San Raffaele, Milan

P. Valsasina

Neuroimaging Research Unit, Department of Neurology, Scientific Institute and University San Raffaele, Milan

L. Bonzano

Department of Neuroscience, Ophtalmology and Genetics, University of Genoa, Genoa

MP Sormani

Neuroimaging Research Unit, Department of Neurology, Scientific Institute and University San Raffaele, Milan, Biostatistics Unit, Department of Health Sciences, University of Genoa, Genoa

R. Saccardi

Bone Marrow Transplantation Unit, University of Florence, Florence, Italy

GL Mancardi

Department of Neuroscience, Ophtalmology and Genetics, University of Genoa, Genoa

M. Filippi

Neuroimaging Research Unit, Department of Neurology, Scientific Institute and University San Raffaele, Milan, filippi.massimo{at}hsr.it

for the Italian GITMO-NEURO Intergroup on Autologous Stem Cell Transplantation

Using MRI, we measured disease activity and brain atrophy in nine multiple sclerosis patients treated with autologous hematopoietic stem cell transplantation (AHSCT) for a mean follow up of 63 months. We show that AHSCT is associated to a longlasting suppression of inflammation and to a marked decrease of the rate of brain atrophy after the second year following treatment. Multiple Sclerosis 2007; 13 : 1068—1070. http://msj.sagepub.com

Key Words: atrophy • autologous hematopoietic stem cell transplantation • magnetic resonance imaging • multiple sclerosis

This version was published on September 1, 2007

Multiple Sclerosis, Vol. 13, No. 8, 1068-1070 (2007)
DOI: 10.1177/1352458507076982


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. Awad and O. Stuve Review: Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms Therapeutic Advances in Neurological Disorders, November 1, 2009; 2(6): 357 - 368. [Abstract] [PDF]

				R. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stuve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, and O. Khan Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis Neurology, July 8, 2008; 71(2): 136 - 144. [Abstract] [Full Text] [PDF]